BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, April 23, 2026
Home » Blogs » BioWorld MedTech Perspectives » Ditching Medicare: Maybe crazy, but tougher than you think

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

Medical technology / Medicare

Ditching Medicare: Maybe crazy, but tougher than you think

Feb. 12, 2012
By Mark McCarty

Whaddaya, nuts or somethin'?

There are many definitions for the word “crazy,” and here's another. Crazy is when you want to get out of Medicare and save the government and the taxpayer money, but the government won't let you.

Recent reports indicate that a group of five senior citizens, including former Texas Republican congressman Dick Armey, are okay with their Social Security benefits, but that the law is forcing them to enroll in Medicare Part A if they want to stay on Social Security.

The case made it to the Court of Appeals for the District of Columbia, and maybe the fact that the case was in DC should have tipped everyone off. After all, DC is the jurisdiction that passed a law stating that the city's rats could not be killed, but had to be trucked 25 miles away from the city and released on the unsuspecting citizens of Virginia and Maryland.

In any event, Judges Brett Kavanaugh and Douglas Ginsburg are said to have told the five seniors, “we're sorry. We get it, but the law doesn't.”

Between Medicare and Social Security, Medicare is expected to cost much more in the years to come, but instead of allowing retirees to take just Social Security and leave the Medicare money on the table, everyone has to take both or neither.

One might assume there is no mass exodus from Medicare among impending retirees, but what sane person would take Medicare over private insurance? Let's assume one of every 10 Baby Boomers can stay on their private insurance for the rest of their lives. If you assume there are 78 million Boomers, that's 7.8 million who might forswear Medicare.

According to the Kaiser Family Foundation, the average Medical cost per beneficiary is more than $8,300, and Kaiser also suggests that Part A accounted for 41% of Medicare spending in 2007. That would come to roughly $3,300 per year. Multiply that average cost by 7.8 million and you get how much in savings by dropping this requirement?

About $25.6 billion per year, that's how much. But even if only 5% of Boomers could carry private insurance until death do part them from this world, that's more than $12 billion a year. If you assume those Boomers will last about 20 years after retirement, hardly a stretch of the imagination according to CDC, we're talking $120 billion at least, maybe $250 billion.

Whichever number you choose, that's a lot of money. It might not be enough to fix the Medicare financing mess, but there is no one adjustment that will. But hey, let's not mess with success, shall we? Government rules are what got us here, so why not roll with it?

Oh yeah, another definition of crazy? Doing the same thing over and over again and expecting a different outcome. Now that's just crazy.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 22, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing